DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) today announced completion of CE marking (market approval) in Europe for HOMECHOICE CLARIA, an automated peritoneal dialysis (APD ...
With one in four APD patients globally benefitting from Baxter’s two-way remote patient management technology, Sharesource offers patients and clinicians the ability to stay closely connected to ...
Baxter International Inc. BAX recently announced that it has received CE marking approval in Europe for HOMECHOICE CLARIA – its automated peritoneal dialysis (APD) system integrated with the ...
DEERFIELD, Ill., December 11, 2001 - Baxter Healthcare Corporation announced today it has received clearance from the U.S. Food and Drug Administration (FDA) to market its HomeChoice Pediatric ...
The Food & Drug Administration warns Baxter Healthcare Corp. about problems with its HomeChoice peritoneal dialysis systems after reports of patients developing peritonitis. The Food & Drug ...
Baxter Healthcare Corporation announced today that the U.S. Food and Drug Administration (FDA) has classified Baxter’s recent Urgent Product Recall regarding Increased Intraperitoneal Volume (IIPV), ...
Baxter International Inc. BAX recently attained FDA approval for the Homechoice Claria automated peritoneal dialysis (APD) system with Sharesource connectivity platform. It is worth mentioning here ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results